Estia Health Ltd (ASX: EHE) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Estia Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $797.76 million
P/E Ratio 169.49
Dividend Yield 5.13%
Shares Outstanding 259.86 million
Earnings per share -0.268
Dividend per share 0.16
Year To Date Return 55.89%
Earnings Yield 0.59%
Franking 100%
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • Estia Health Ltd (ASX: EHE)
    Latest News

    Three exuberant runners dash towards the camera. One raises her arms in triumph; another jumps in the air with arms raised. The third runner gives a satisfied smile.
    Small Cap Shares

    Catch 'em before it's too late: 3 ASX small-cap shares that just started soaring

    These stocks have risen in the last quarter, and NovaPort analysts reckon it's just the beginning.

    Read more »

    Five guys in suits wearing brightly coloured masks, they are corporate superheroes.
    Share Market News

    5 ASX 300 directors buying up their company shares in the past week

    These five ASX shares have seen their own management buying up stock.

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Estia Health, GQG, GUD, and Pilbara Minerals shares are storming higher

    These ASX shares are starting the week strongly.

    Read more »

    healthcare worker overseeing group of aged care residents at table
    Mergers & Acquisitions

    Why is this ASX 300 healthcare share charging 9% higher today?

    Today’s a big deal for Estia shareholders.

    Read more »

    young boys open mouthed in front of shares graph
    Share Market News

    Returning capital: These ASX companies have been buying back their shares in 2023

    Do you own any of these capital-returning shares?

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Estia Health, Graincorp, Novonix, and Polynovo shares are racing higher

    These ASX shares are having particularly strong sessions on Wednesday.

    Read more »

    Three different coloured arrows going up, symbolising a rising share price and record highs.
    Share Gainers

    3 ASX All Ords shares rocketing over 10% on big news

    It's a good day to be invested in these stocks.

    Read more »

    Two kids in superhero capes.

    Why this fund manager thinks these 2 outperforming ASX shares can keep beating the market

    These ASX shares could be a great way for investors to beat the market.

    Read more »

    a man holds a firework sparkler in both hands as a shower of sparkly confetti falls from the sky around him as he smiles and closes his eyes in a celebratory scene.
    Investing Strategies

    'Attractive valuations': 2 ASX shares to buy now before they explode

    Two experts tip a pair of stocks that are still looking cheap despite businesses that are performing well.

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Core Lithium, Estia Health, Kingsgate, and St Barbara shares are charging higher

    These ASX shares are having a strong finish to the week.

    Read more »

    Two mature-age people, a man and a woman, jump in unison with their arms and legs outstretched on a sunny beach.
    Mergers & Acquisitions

    Estia Health share price jumps 21% on takeover approach

    This aged care operator is in the crosshairs of a private equity giant.

    Read more »

    man jumping for joy carrying shopping bags
    Cheap Shares

    I think value investors would love to buy these 2 cheap ASX shares

    These two shares could deliver for investors.

    Read more »

    Frequently Asked Questions

    Yes, Estia Health has historically paid two fully franked shareholder dividends a year.

    Estia Health generally pays its shareholder dividends in March and September.

    Yes, Estia Health has a dividend reinvestment plan (DRP) which allows eligible shareholders to invest all or part of their dividend payments into additional fully paid shares. The extent to which the DRP applies to future dividends is included as part of each dividend announcement.

    Estia Health Ltd listed on the ASX on 5 December 2014.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    25 Aug 2023 $0.1200 100.00% Final 15 Sep 2023
    24 Feb 2023 $0.0370 100.00% Interim 17 Mar 2023
    25 Feb 2022 $0.0235 100.00% Interim 18 Mar 2022
    27 Aug 2021 $0.0230 100.00% Final 17 Sep 2021
    28 Feb 2020 $0.0540 100.00% Interim 27 Mar 2020
    04 Sep 2019 $0.0780 100.00% Final 02 Oct 2019
    05 Mar 2019 $0.0800 100.00% Interim 27 Mar 2019
    06 Sep 2018 $0.0800 100.00% Final 28 Sep 2018
    01 Mar 2018 $0.0780 100.00% Interim 23 Mar 2018
    07 Sep 2017 $0.0000 100.00% Final 29 Sep 2017
    30 Sep 2016 $0.1280 100.00% Final 07 Nov 2016
    22 Mar 2016 $0.1280 100.00% Interim 20 Apr 2016

    EHE ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Estia Health Ltd

    Estia Health Ltd (ASX: EHE) operates residential aged care facilities in Australia. The company has more than 70 facilities in Victoria, South Australia, New South Wales, and Queensland. Estia's facilities provide accommodation, clinical care, and daily living services for around 8,000 residents. The company's clinical care services include 24-hour nursing care, personal care, wound management, administering pharmaceuticals, physiotherapy, and occupational therapy. Federal government funding makes up the majority of Estia's total revenue.

    EHE Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    04 Dec 2023 $3.07 $-0.01 -0.32% 574,196 $3.08 $3.08 $3.07
    01 Dec 2023 $3.08 $0.01 0.33% 523,746 $3.07 $3.08 $3.07
    30 Nov 2023 $3.07 $0.00 0.00% 888,427 $3.07 $3.08 $3.07
    29 Nov 2023 $3.07 $0.02 0.66% 1,738,899 $3.07 $3.08 $3.07
    28 Nov 2023 $3.05 $0.00 0.00% 207,068 $3.05 $3.06 $3.05
    27 Nov 2023 $3.05 $0.00 0.00% 383,114 $3.05 $3.06 $3.05
    24 Nov 2023 $3.05 $0.00 0.00% 473,964 $3.06 $3.06 $3.05
    23 Nov 2023 $3.05 $0.00 0.00% 535,154 $3.06 $3.06 $3.05
    22 Nov 2023 $3.05 $-0.01 -0.33% 663,172 $3.06 $3.06 $3.05
    21 Nov 2023 $3.06 $0.01 0.33% 859,600 $3.05 $3.06 $3.05
    20 Nov 2023 $3.05 $0.00 0.00% 708,152 $3.06 $3.06 $3.05
    17 Nov 2023 $3.05 $0.00 0.00% 8,217,820 $3.05 $3.06 $3.05
    16 Nov 2023 $3.05 $0.00 0.00% 699,520 $3.05 $3.06 $3.05
    15 Nov 2023 $3.05 $0.00 0.00% 1,241,649 $3.05 $3.06 $3.04
    14 Nov 2023 $3.05 $-0.01 -0.33% 786,954 $3.05 $3.06 $3.04
    13 Nov 2023 $3.06 $0.01 0.33% 2,993,455 $3.04 $3.06 $3.04
    10 Nov 2023 $3.05 $-0.01 -0.33% 2,009,759 $3.06 $3.06 $3.02
    09 Nov 2023 $3.06 $0.00 0.00% 370,527 $3.06 $3.06 $3.05
    08 Nov 2023 $3.06 $0.00 0.00% 455,244 $3.06 $3.06 $3.05
    07 Nov 2023 $3.06 $0.01 0.33% 818,499 $3.05 $3.06 $3.05

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    24 Aug 2023 Sean Bilton Exercise 343,261 $1,070,974
    Conversion of securities. 590,594 LTI Performance Rights
    24 Aug 2023 Sean Bilton Buy 343,261 $1,070,974
    Conversion of securities.
    02 Mar 2023 Karen Penrose Buy 7,238 $14,982
    On-market trade.
    24 Feb 2023 Gary Weiss Buy 25,000 $51,750
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Gary Hilton Weiss Non-Executive DirectorNon-Executive Chairman Feb 2016
    Mr Weiss has international business experience and has been involved in numerous cross-border mergers and acquisitions. Gary is Chairman of Cromwell Property Group Limited and Ardent Leisure Group Limited, Executive Director of Ariadne Australia Limited, and a Director of Thorney Opportunities Limited and Hearts and Minds Investments Limited. Gary is also a Commissioner of the Australian Rugby League Commission and a Director of the Victor Chang Cardiac Research Institute. Gary was Chairman of Coats Group plc from May 2004 to April 2012, Chairman of Clearview Wealth Ltd from 2013 to May 2016, Chairman of Ridley Corporation from June 2015 to June 2020, Executive Director of Guinness Peat Group plc from 1990 to April 2011 and has held directorships of numerous companies, including The Straits Trading Co Limited, Tag Pacific Limited, Pro-Pac Packaging Limited, Premier Investments Ltd, Westfield Group, Tower Australia Limited, Australian Wealth Management Limited, Tyndall Australia Limited, Joe White Maltings Limited, CIC Limited, Whitlam Turnbull & Co Limited and Industrial Equity Limited. Gary has authored numerous articles on a variety of legal and commercial topics. Gary was awarded a Member of the Order of Australia (AM) in recognition of his significant services to business and to the community.
    Ms Helen Kurincic Non-Executive Director Jul 2017
    Ms Kurincic has executive and non-executive experience across the healthcare sector. Helen is Chairman of Integral Diagnostics Limited and McMillan Shakespeare Limited, and a Non-executive Director of HBF Health Limited. Helen was previously the Chief Operating Officer and Director of Genesis Care for seven years from early inception in 2007, creating Australia's largest radiation oncology and cardiology service business. Previous roles also include Non-executive Director of Sirtex Medical Limited, Non-executive Director of DCA Group Limited which included residential aged care in Australia and New Zealand, Non-executive Director of AMP Capital Investor's aged care business Domain Principal Group, CEO and Executive Director of residential aged care provider Benetas and Board member of Melbourne Health and Orygen Research Centre. Helen has also been actively involved in government policy reform across various areas of the healthcare sector.
    Ms Karen Lee Collett Penrose Non-Executive Director Oct 2018
    Ms Penrose is an experienced Company Director who has served as a full-time Non-executive Director since 2014 on the boards of ASX listed companies across the financial services, aged care, healthcare, resources and infrastructure sectors. Karen's executive career was in leadership and CFO roles, mainly in financial services. Karen worked with CBA and HSBC for over 20 years. She is Board and Governance 16 Estia Health | 2022-23 Annual Report 2022-23 Annual Report | Estia Health 17 About this report Chairman and CEO's Review Key Highlights About Estia Health Board and Governance Corporate Governance Executive Leadership Team COVID-19 Sustainability Risk Management Tax Transparency Report Annual Financial Report about consumer outcomes, financial management and well-versed in operating in a rapidly changing regulatory environment. Karen is a Director and Chair of the Audit Committee of Bank of Queensland, Ramsay Health Care and Cochlear. She is also Director of Marshall Investments Pty Ltd and Rugby Australia Limited. Karen was formally a director of Vicinity Centres, Future Generation Global Investment Company Limited, AWE Limited and Spark Infrastructure Group Limited. Karen is a member of Chief Executive Women.
    Ms Norah Kathleen Barlow Non-Executive Director Nov 2014
    Ms Barloe is amongst Australasia's experienced executives and directors, with an in-depth knowledge of the aged and health care sector. Norah also holds experience as the highly respected former CEO and former Director of Summerset Group, an NZX and ASX-listed company named Australasia's best retirement village operator for four years running. Norah has a strong background across business leadership and management, strategy, corporate finance, governance, tax and accounting. Norah was President of the Retirement Villages Association (NZ) for seven years and made an Officer of the New Zealand Order of Merit for services to business in 2014. Norah was also a Non-executive Director of Ingenia Communities Group, Evolve Education Group Limited, and chair of the Audit Committee for Methven Limited. Norah stepped down as CEO of Estia Health in November 2018 and remains on the board as a Non-executive Director. Norah is currently Chief Executive of Heritage Lifecare Limited.
    Mr Paul Foster Non-Executive Director Feb 2016
    Mr Foster is an experienced Financial Services professional and Company Director, with more than 20 years of investment experience in the infrastructure, private equity and real estate asset classes, including substantial investments in the healthcare sector. Paul is a Managing Director at Pacific Equity Partners, one of Australia's largest alternative investment management firms. He is also a Director of PEP Services Pty Ltd and PEP Advisory Services Pty Ltd. Paul was a Director of the Opal Aged Care Group between 2010 and 2015 and was Chairman of the Group in 2011. Paul was head of AMP Capital's Infrastructure investment business in Australia and New Zealand until 2015. Before AMP Capital, he was an investment professional at Macquarie Group and Perpetual Investments.
    Mr Sean Bilton Chief Executive OfficerManaging Director Jul 2022
    Mr Bilton was previously in the roles of Chief Operating Officer and Deputy CEO since October 2018. Sean has also overseen the successful commissioning of three new homes and consideration of future growth opportunities. His success in leading the company through an unprecedented and complex period of change during the COVID-19 pandemic and the Aged Care Royal Commission ensured Estia Health's continued standing in the sector. During his tenure, Sean has worked closely with the Chief People Officer on the development and operationalisation of Estia Health's employee attraction and retention strategy. Sean has worked for more than 15 years in the sector, his involvement commencing as an Asset Manager at AMP Capital where he managed the integration of multiple acquisitions, which were the genesis of the Opal Healthcare business. When joining Opal as the Head of Commercial in 2010, Sean was responsible for overseeing the acquisition and development led growth of the business, as well as customer acquisition, communications, and marketing.
    Professor Simon Willcock Non-Executive Director Sep 2022
    Mr Willcock was appointed to the Board on 1 September 2022. He is a General Practitioner and the Director of Primary Care and wellbeing at MQ Health. He was previously Head of the Discipline of General Practice in the University of Sydney Medical Program. Simon trained as a rural procedural GP and practiced in Inverell, NSW for seven years. For the past thirty years he has worked in academic and clinical practice in Sydney and has had a number of educational leadership roles. Simon was until recently an elected board member and Chair of the Avant Mutual Group and is currently an elected board member and Deputy Chair of the Sydney North Health Network.
    Ms Leanne Ralph Company Secretary Apr 2019
    Steve Lemlin Chief Financial Officer
    Damian Hiser Chief Operating Officer
    Leanne Ralph Company Secretary

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Citicorp Nominees Pty Limited 60,041,234 23.11%
    J P Morgan Nominees Australia Pty Limited 43,761,862 16.84%
    Hsbc Custody Nominees (Australia) Limited 43,263,097 16.65%
    National Nominees Limited 22,533,849 8.67%
    Bnp Paribas Noms Pty Ltd <Drp> 12,407,006 4.77%
    Argo Investments Limited 10,809,250 4.16%
    Hsbc Custody Nominees (Australia) Limited A/C 2 5,079,719 1.96%
    Hsbc Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 4,529,998 1.74%
    Neweconomy.Com.Au Nominees Pty Limited <900 Account> 4,451,693 1.71%
    Emalyn Holdings Pty Limited <John Kennedy A/C> 4,102,766 1.58%
    Mrs Julia Michelle Manken & Mr Mike Darren Manken & Miss Jessica Kelly Manken 2,135,000 0.82%
    Mr Mark Edward Kennedy <Mark Edward Kennedy A/C> 1,910,678 0.74%
    Pacific Custodians Pty Limited <Ehe Emp Sub Register> 1,593,513 0.61%
    Skip Enterprises Pty Ltd <Farquhar A/C> 1,442,768 0.56%
    Mark Edward Kennedy <Mark Edward Kennedy Family> 1,277,438 0.49%
    Kennbros Pty Limited 1,156,834 0.45%
    Riviera Health Pty Ltd <Manken Family Super A/C> 864,750 0.33%
    Custodial Services Limited <Beneficiaries Holding A/C> 612,724 0.24%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 600,459 0.23%
    Mr Ian Ronald Thorley 584,326 0.22%